This article is more than 5 years old. Information may no longer be current.

FDA again seeking information and public comment on LASIK devices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The U.S. Food and Drug Administration announced it is reopening a public docket to gather information and comments on LASIK devices, according to a notice published in the Federal Register. The FDA will accept comments and observations until Nov. 15, 2010.

"At this time, the agency is reopening the docket to continue to receive public comments," the notice said. "Information and comments submitted to the docket will assist us in identifying ways in which we can improve our public outreach efforts regarding the safety and effectiveness of LASIK devices."

The docket was previously open between Sept. 12, 2008, and Sept. 14, 2009.

Comments or information can be submitted electronically at www.regulations.gov. Written submissions can be sent to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. The docket number - FDA-2008-N-0488 - must be included with submitted comments.

Comments submitted to the docket are public information and may be posted on the FDA Web site at www.fda.gov.

In early 2008, the FDA heard public testimony on low patient satisfaction stemming from poor visual outcomes and complications after LASIK.